Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
US12178874B2 · kind B2 · utility
0Cited by
29References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2018 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Mar 12, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ophthalmic formulations comprising aflibercept and a lysine salt tonicifying agent are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.